Answers are grounded in this paper and cite their sources.
Background & Aims: Although it is well documented that iron promotes hepatocyte death in chronic liver disease, recent studies have suggested that iron in hepatocytes also has a protective role against such disease. However, the mechanisms underlying this beneficial role of iron remain poorly understood. Methods: F-box and leucine-rich repeat protein 5 (FBXL5) is a substrate recognition component of the SCF E3 ligase complex that restricts intracellular iron levels. To investigate the role of hepatic iron in the pathogenesis of cholestatic liver disease, liver-specific FBXL5-deficient or control mice were fed a diet supplemented with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (n = 3-12). Moreover, matrix metalloproteinase (MMP)-9 expression and liver fibrosis were analyzed in liver specimens obtained from 37 patients with primary biliary cholangitis (PBC). Conclusions: Our data link hepatocyte iron with fibrolysis pathways in the setting of chronic liver disease. Thus, the present study provides insights into the pro-resolving roles of neutrophils in cholestatic liver disease. Impact and implications: fibrolytic neutrophils. In addition, hepatic MMP9 expression is inversely associated with liver fibrosis in patients with PBC. These findings reveal a protective role for hepatocyte iron and offer new therapeutic insights for chronic liver disease.
No takes yet. Share an insight, caveat, or question.
Kanamori et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: